NYSE Composite ended the session with AbbVie jumping 2.48% to $112.50 on Wednesday, after four consecutive sessions in a row of gains. NYSE Composite dropped 0.01% to $15,008.89, following last session’s upward trend on what was a somewhat negative trend trading session today.
AbbVie today’s close was $112.50, 0.81% below its 52-week high of $113.41.
AbbVie’s sales growth is 57.7% for the ongoing quarter and 50.4% for the next. The company’s growth estimates for the present quarter and the next is 29.4% and 18.2%, respectively.
Year-on-year quarterly revenue growth grew by 52.2%, now sitting on 40.65B for the twelve trailing months.
AbbVie’s last day, last week, and last month’s average volatility was 0.70%, 0.61%, and 0.10%, respectively.
AbbVie’s last day, last week, and last month’s high and low average amplitude percentage was 1.52%, 1.96%, and 2.01%, respectively.
AbbVie’s Stock Yearly Top and Bottom Value
AbbVie’s stock is valued at $112.50 at 17:30 EST, below its 52-week high of $113.41 and way higher than its 52-week low of $62.55.
AbbVie’s Moving Average
AbbVie’s value is above its 50-day moving average of $105.44 and way higher than its 200-day moving average of $95.77.